Page 1 of 1

Ocrelizumab gains positive CHMP opinion for RRMS and PPMS

Posted: Fri Nov 10, 2017 6:26 am
Roche, the makers of ocrelizumab have today announced that the Committee for Medicinal Products for Human Use (CHMP) has given a positive opinion for the use of ocrelizumab in adults with active relapsing remitting multiple sclerosis (RRMS) and primary progressive multiple sclerosis (PPMS)...Read more - ... s-and-ppms